Persuasion, Adaptation, and Double Identity: Qualitative Study on the Psychological Impact of a Screen-Detected Colorectal Cancer Diagnosis

被引:2
|
作者
McGregor, Lesley M. [1 ]
Tookey, Sara [1 ]
Raine, Rosalind [2 ]
von Wagner, Christian [1 ]
Black, Georgia [2 ]
机构
[1] UCL, Dept Behav Sci & Hlth, London WC1E 6BT, England
[2] UCL, Dept Appl Hlth Res, London WC1E 6BT, England
关键词
OCCULT BLOOD-TEST; EXPERIENCE; INFORMATION; BELIEFS; ILLNESS; HEALTH;
D O I
10.1155/2018/1275329
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The NHS Bowel Cancer Screening Programme (BCSP) is aimed at reducing colorectal cancer (CRC) mortality through early detection within a healthy population. This study explores how 5 people (three females) experience and make sense of their screen-detected diagnosis and the psychological implications of this diagnostic pathway. A biographical narrative interview method was used, and transcripts were analysed using a thematic analysis with a phenomenological lens. Themes specifically relating to posttreatment experience and reflections are reported here: Do it: being living proof, Resisting the threat of recurrence, Rationalising bodily change, and Continuing life-"carrying on normally." Participants described their gratefulness to the BCSP, motivating a strong desire to persuade others to be screened. Furthermore, participants professed a duality of experience categorised by the normalisation of life after diagnosis and treatment and an identification of strength post cancer, as well as a difficulty adjusting to the new changes in life and a contrasting identity of frailty. Understanding both the long-and short-term impacts of a CRC diagnosis through screening is instrumental to the optimisation of support for patients. The results perhaps highlight a particular target for psychological distress reduction, which could reduce the direct and indirect cost of cancer to the patient.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Does preoperative diagnosis reduce the number of operations required for treatment of screen-detected breast cancer?
    G Ralleigh
    M Michell
    S Henderson
    S Bose
    Breast Cancer Research, 2 (Suppl 2)
  • [42] Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
    Elizabeth Walsh
    Colin J Rees
    Michael Gill
    Clare E Parker
    Roisin Bevan
    Sarah L Perry
    Yvonne Bury
    Sarah Mills
    D Michael Bradburn
    Michael Bramble
    Mark A Hull
    British Journal of Cancer, 2016, 115 : 261 - 265
  • [43] Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
    Walsh, Elizabeth
    Rees, Colin J.
    Gill, Michael
    Parker, Clare E.
    Bevan, Roisin
    Perry, Sarah L.
    Bury, Yvonne
    Mills, Sarah
    Bradburn, D. Michael
    Bramble, Michael
    Hull, Mark A.
    BRITISH JOURNAL OF CANCER, 2016, 115 (02) : 261 - 265
  • [44] Screen-detected gallstone disease and risk of liver and pancreatic cancer: The Kailuan Cohort Study
    Zhao, Xinyu
    Wang, Na
    Sun, Yuanyuan
    Zhu, Guoling
    Wang, Yanhong
    Wang, Zhenyu
    Zhang, Yanmin
    Cheng, Kailiang
    Wang, Guodong
    Wu, Shouling
    Wang, Li
    LIVER INTERNATIONAL, 2020, 40 (07) : 1744 - 1755
  • [45] RISK-FACTORS FOR SCREEN-DETECTED BREAST-CANCER - A CASE CONTROL STUDY
    JOENSUU, H
    TUOMINEN, J
    HINKKA, S
    KLEMI, P
    TOIKKANEN, S
    RASANEN, O
    PARVINEN, I
    ACTA ONCOLOGICA, 1992, 31 (07) : 729 - 732
  • [46] Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival
    Kobayashi, N.
    Hikichi, M.
    Ushimado, K.
    Sugioka, A.
    Kiriyama, Y.
    Kuroda, M.
    Utsumi, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1232 - 1240
  • [47] Differences in subtype distribution between screen-detected and symptomatic invasive breast cancer and their impact on survival
    N. Kobayashi
    M. Hikichi
    K. Ushimado
    A. Sugioka
    Y. Kiriyama
    M. Kuroda
    T. Utsumi
    Clinical and Translational Oncology, 2017, 19 : 1232 - 1240
  • [48] IGF-axis and screen-detected prostate cancer: A cross-sectional study
    Oliver, SE
    Jefferson, K
    Gunnell, D
    Persad, R
    Donovan, JL
    Peters, TJ
    Gillatt, D
    Pearce, A
    Hamdy, F
    Neal, DE
    Holly, J
    JOURNAL OF UROLOGY, 2003, 169 (04): : 161 - 161
  • [49] Observational study on screen-detected prostate cancer: case series of empirical clinical practice
    Takahashi, Takeshi
    BJU INTERNATIONAL, 2025, 135 (01) : 177 - 178
  • [50] Danish citizens' perspectives on the preventive medication recommended after screen-detected cardiovascular disease: A qualitative study
    Hojgaard, Helen Gras
    Frederiksen, Kirsten
    Hogh, Annete Langager
    Rasmussen, Bodil
    Dahl, Marie
    SCANDINAVIAN JOURNAL OF CARING SCIENCES, 2024, 38 (03) : 802 - 814